At 8.3% CAGR, North America Fill Finish Manufacturing Market is Projected to be Worth US$ 6,505.56 Million by 2030, says Business Market Insights

According to Business Market Insights’ research, the North America fill finish manufacturing market was valued at US$ 3,439.58 million in 2022 and is expected to reach US$ 6,505.56 million by 2030, registering a CAGR of 8.3% from 2022 to 2030. Single-Use systems for aseptic fill finish and significant pipeline for biologics are among the critical factors attributed to the North America fill finish manufacturing market expansion.

Single-use disposable systems (SUDS) and single-use systems (SUS) for aseptic fill finish save time for pharmaceutical manufacturers, thereby allowing them to streamline their operations and shorten project schedules. Incorporating SUDS also helps them ensure regulatory compliance as well as confer environmental, health, and safety (EHS) benefits and facility design advantages. Furthermore, SUS accelerates the change over fill finish operations by simplifying end-of-batch breakdown and decontamination operations; the simplification of decontamination operations involves the elimination of time-consuming cleaning and preparation steps. The SUS is now being used in fill-finish operations. Bulk biotech operations have successfully deployed single-use systems for buffer and media preparations. They are currently implementing new single-use technologies such as fermentation and chromatography systems. Recent advancements in technology are making SUDS increasingly attractive for aseptic operations. For instance, a single-use line is a perfect fit for parenteral solution products with relatively low batch sizes (50—500L) that a peristaltic pump can transfer. Thus, rise in use of single use system for aseptic fill finish manufacturing will provide future trends in near future.

On the contrary, growing competition in biopharmaceutical contract manufacturing industry hurdles the growth of North America fill finish manufacturing market.

Based on product, the North America fill finish manufacturing market is bifurcated into consumables and instruments. The consumables segment held 57.8% share of North America fill finish manufacturing market in 2022, amassing US$ 1,989.50 million. It is projected to garner US$ 3,846.79 million by 2030 to expand at 8.6% CAGR during 2022–2030. Furthermore, the consumables is sub segmented into prefilled syringes, glass vial/plastic vials, cartridges, and others.

In terms of modality, the North America fill finish manufacturing market is categorized into recombinant proteins, monoclonal antibodies, vaccines, cell therapies and biological therapies, gene therapies, and others. The vaccines segment held 33.0% share of North America fill finish manufacturing market in 2022, amassing US$ 1,135.02 million. It is projected to garner US$ 2,242.79 million by 2030 to expand at 8.9% CAGR during 2022–2030.

By end user, the North America fill finish manufacturing market is segmented into contract manufacturing organizations, biopharmaceutical companies, and others. The contract manufacturing organizations segment held 47.3% share of North America fill finish manufacturing market in 2022, amassing US$ 1,627.16 million. It is projected to garner US$ 3,152.16 million by 2030 to expand at 8.6% CAGR during 2022–2030.

Based on country, the North America fill finish manufacturing market has been categorized into the US, Canada, and Mexico.  Our regional analysis states that the US captured 83.2% share of North America fill finish manufacturing market in 2022. It was assessed at US$ 2,862.07 million in 2022 and is likely to hit US$ 5,466.38 million by 2030, exhibiting a CAGR of 8.4% during 2022–2030.

Key players operating in the North America fill finish manufacturing market are Becton Dickinson and Co, Gerresheimer AG, Groninger and Co GmbH, IMA Industria Macchine Automatiche SpA, Maquinaria Industrial Dara SL, Nipro Medical Europe NV, NNE AS, Optima Packaging Group Gmbh, Schott AG, SGD SA, Stevanato Group SpA, Syntegon Technology GmbH, and West Pharmaceutical Services Inc, among others.

• In October 2023, Dara Pharma will be present at CPhI, sharing the Booth 2C29 with its partner ARaymond, and will exhibit a filling and closing machine for vials in nest and RayDyLyo caps, model NFL/2-RDL.
• In November 2022, SGD Pharma announced the launch of its latest sustainable innovation, Eclipse, an eco-designed, refillable packaging solution for the Beauty industry. Eclipse offers consumers an effortless replacement and recycling experience.

Contact Us
Phone: +16467917070
Email Id: sales@businessmarketinsights.com